InvestorsHub Logo
Followers 117
Posts 33453
Boards Moderated 3
Alias Born 10/22/2007

Re: None

Tuesday, 11/27/2012 6:54:14 PM

Tuesday, November 27, 2012 6:54:14 PM

Post# of 10237
ACAD / ACADIA Announces Pimavanserin Meets Primary & Key Secondary Endpoints in Pivotal Phase III Parkinson’s Disease Psychosis

http://ih.advfn.com/p.php?pid=nmona&article=55195327

Longterm Investment, Biotechs & High Yield Dividend Stocks ... #board-11828

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.